FDMT
4D Molecular TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
12
U.S. public peers
Grade Position
Below peers
vs peer average
FDMT vs peer average
17/100
FDMT vs. peer average (F vs. C)
Grade spread
A 3 · B 1 · C 3 · D 2 · F 2
Graded peers loaded
Coverage
11 graded
92% of tracked
Peer overview
RCKT is the first available peer comparator.
Rare‑disease gene therapy company with similar clinical/financing binary risks.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
FDMT
4D Molecular Therapeutics
RCKT
Rocket
Grade
F
C
Momentum
44
9
Value
41
41
Sentiment
0
100
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs RCKT
FDMT / RCKT
Grade Position
Below peers
FDMT vs. peer average (F vs. C)
17/100
Momentum
44
FDMTValue
41
FDMTSentiment
0
RCKTRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs FDMT
RCKT is the first peer returned for this comparison set.